mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |